Citation Impact
Citing Papers
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
2010 Standout
Gastric but not duodenal motor effects of oral erythromycin are dose related
1995
Lumbar intrathecal administration of naloxone antagonizes analgesia produced by electrical stimulation of the hypothalamic arcuate nucleus in pentobarbital-anesthetized rats
1990
Are poor metabolisers of sparteine/debrisoquine less pain tolerant than extensive metabolisers?
1993
Delayed gastric emptying (DGE) after pancreatic surgery: A suggested definition by the International Study Group of Pancreatic Surgery (ISGPS)
2007 Standout
Gastric feeding with erythromycin is equivalent to transpyloric feeding in the critically ill
2001
Gastrointestinal motility disorders in scleroderma
1994 Standout
Phantom limb pain
2001 Standout
Gastric emptying in diabetes: clinical significance and treatment
2002
Gastrointestinal dysfunction in Parkinson's disease
2003 Standout
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Bowel Disorders
2016 Standout
Vagus-Dependent and Vagus-Independent Mechanisms of Action of the Erythromycin Derivative EM574 and Motilin in Dogs
1996 StandoutNobel
Acupuncture: neuropeptide release produced by electrical stimulation of different frequencies
2002 Standout
ESPEN Guidelines on Parenteral Nutrition: Intensive care
2009 Standout
ESPEN guideline on clinical nutrition in the intensive care unit
2018 Standout
Motilin and Clinical Application
1997
Ischemic but Not Thermal Pain Sensitivity Varies Across the Menstrual Cycle
1997
Cisapride
1994
Erythromycin stimulates gastric emptying after esophagectomy with gastric replacement: A randomized clinical trial
1996
Review article: 5‐hydroxytryptamine agonists and antagonists in the modulation of gastrointestinal motility and sensation: clinical implications
1992
Strategies to modulate the intestinal microbiota and their effects on nutrient utilization, performance, and health of poultry
2019 Standout
Esophageal Cancer
2003 Standout
Effects of Cisapride on Cholinergic Neurotransmission and Propulsive Motility in the Guinea Pig Ileum
1989
In vitro Pharmacological Characterization of Mitemcinal (GM-611), the First Acid-Resistant Non-Peptide Motilin Receptor Agonist, in Smooth Muscle of Rabbit Small Intestine
2006 StandoutNobel
The Serotonin Signaling System: From Basic Understanding To Drug Development for Functional GI Disorders
2007 Standout
Effects of Motilin and Mitemcinal (GM-611) on Gastrointestinal Contractile Activity in Rhesus Monkeys In Vivo and In Vitro
2007 StandoutNobel
Indigenous Bacteria from the Gut Microbiota Regulate Host Serotonin Biosynthesis
2015 Standout
Co‐localization of endomorphin‐2 and substance P in primary afferent nociceptors and effects of injury: a light and electron microscopic study in the rat
2004 StandoutNobel
Effects of mitemcinal (GM-611), an orally active erythromycin-derived prokinetic agent, on delayed gastric emptying and postprandial glucose in a new minipig model of diabetes
2008 StandoutNobel
Irritable bowel syndrome
2016 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
ORAL MITEMCINAL (GM‐611), AN ERYTHROMYCIN‐DERIVED PROKINETIC, ACCELERATES NORMAL AND EXPERIMENTALLY DELAYED GASTRIC EMPTYING IN CONSCIOUS DOGS
2007 StandoutNobel
Functional Gut Disorders
1998
Pharmacologic management of neuropathic pain: Evidence-based recommendations
2007 Standout
Mitemcinal (GM-611), an orally active motilin receptor agonist, accelerates colonic motility and bowel movement in conscious dogs
2007 StandoutNobel
Diclofenac residues as the cause of vulture population decline in Pakistan
2004 StandoutNature
Natural products to drugs: natural product-derived compounds in clinical trials
2008 Standout
Effects of Mitemcinal (GM-611), an Acid-Resistant Nonpeptide Motilin Receptor Agonist, on the Gastrointestinal Contractile Activity in Conscious Dogs
2007 StandoutNobel
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient
2016 Standout
Sex, Gender, and Pain: A Review of Recent Clinical and Experimental Findings
2009 Standout
The Functional Gastrointestinal Disorders and the Rome III Process
2006 Standout
Postoperative ileus
1990
Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications?
2002 Standout
Oesophageal carcinoma
2013 Standout
The effect of opioids on phantom limb pain and cortical reorganization
2001
The effect of cisapride on gastro‐oesophageal dysfunction in systemic sclerosis: a controlled manometric study.
1991
Alosetron does not affect the visceral perception of gastric distension in healthy subjects
1994
The role of short-chain fatty acids in microbiota–gut–brain communication
2019 Standout
Alvimopan, a selective peripherally acting μ‐opioid antagonist*
2005
MITEMCINAL (GM‐611), AN ORALLY ACTIVE MOTILIN RECEPTOR AGONIST, IMPROVES DELAYED GASTRIC EMPTYING IN A CANINE MODEL OF DIABETIC GASTROPARESIS
2008 StandoutNobel
Erythromycin and other macrolides as prokinetic agents
1993
Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway
2005 Standout
Serotonin receptors: Subtypes, functional responses and therapeutic relevance
1995
BOARD-INVITED REVIEW: Opportunities and challenges in using exogenous enzymes to improve nonruminant animal production
2011
A review of central 5-HT receptors and their function
1999 Standout
Cisapride
1988
Guidelines for the Provision and Assessment of Nutrition Support Therapy in the Adult Critically Ill Patient:
2009 Standout
ESPEN Guidelines on Enteral Nutrition: Intensive care
2006 Standout
The effects of the opiate antagonist naloxone on measures of cellular immunity during rest and brief psychological stress
1995
Bioactive Metabolites of EM574 and EM523, Erythromycin Derivatives Having Strong Gastrointestinal Motor Stimulating Activity.
1996 StandoutNobel
Antibacterial macrolides: a drug class with a complex pharmacological profile
2004
Comparison of the Antinociceptive Effects Induced by Electroacupuncture and Transcutaneous Electrical Nerve Stimulation in the Rat
1992
Diclofenac Sodium
1988
Psychological Stress and the Human Immune System: A Meta-Analytic Study of 30 Years of Inquiry.
2004 Standout
Does experimental pain response vary across the menstrual cycle? A methodological review
2006
Mitemcinal (GM‐611), an orally active motilin agonist, facilitates defecation in rabbits and dogs without causing loose stools
2007 StandoutNobel
Eating Disorders and the Intestinal Microbiota: Mechanisms of Energy Homeostasis and Behavioral Influence
2017
Postprandial antropyloroduodenal motility and gastric emptying in gastroparesis--effects of cisapride.
1994
Association between Medications That Relax the Lower Esophageal Sphincter and Risk for Esophageal Adenocarcinoma
2000
Effects of EM574 and Cisapride on Gastric Contractile and Emptying Activity in Normal and Drug-Induced Gastroparesis in Dogs
1998
Postsynaptic Signaling via the μ-Opioid Receptor: Responses of Dorsal Horn Neurons to Exogenous Opioids and Noxious Stimulation
2000
Effect of Six Weeks of Treatment With Cisapride in Gastroparesis and Intestinal Pseudo obstruction
1989
Prokinetic agents for lower gastrointestinal motility disorders
1993
American Gastroenterological Association technical review on the diagnosis and treatment of gastroparesis
2004
Inactivation of a Serotonin-Gated Ion Channel by a Polypeptide Toxin from Marine Snails
1998 StandoutScienceNobel
Subpopulations of Gastric Myenteric Neurons Are Differentially Activated via Distinct Serotonin Receptors: Projection, Neurochemical Coding, and Functional Implications
1997
Gender-related differences in IBS symptoms
2001
Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
2010 Standout
Reversal of the Gastric Effects of Nicotine by Nitric Oxide Donor Treatment
2001
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
Functional Gastrointestinal Disorders and Eating Disorders: Relevance of the Association in Clinical Management
1998
EM574, an erythromycin derivative, improves delayed gastric emptying of semi-solid meals in conscious dogs
2000 StandoutNobel
Effect of six weeks of treatment with cisapride in gastroparesis and intestinal pseudoobstruction
1989
Opioid Complications and Side Effects
2008 Standout
Effects of cisapride on gastric and esophageal emptying in progressive systemic sclerosis
1987
Pharmacogenomics: Translating Functional Genomics into Rational Therapeutics
1999 StandoutScience
Challenges and approaches for production of a healthy and functional mayonnaise sauce
2019 Standout
Works of G Gaupmann being referenced
Lack of systematic effects of the 5‐hydroxytryptamine 3 receptor antagonist ICS 205‐930 on gastric emptying and antral motor activity in patients with primary anorexia nervosa.
1991
Effects of oral cisapride on interdigestive jejunal motor activity, psychomotor function, and side-effect profile in healthy man
1987
Naloxone does not alter the perception of pain induced by electrical and thermal stimulation of the skin in healthy humans
1988
Effects of cisapride on postcibal jejunal motor activity
1989
Effects of 3‐days' intake of a sustained‐release preparation of the nitric oxide donor, isosorbide dinitrate, on oesophageal motility
1997
Effects of the prodrug loperamide oxide, loperamide, and placebo on jejunal motor activity
1992
Gastric Emptying, Body Weight and Symptoms in Primary Anorexia Nervosa
1993
Erythromycin effects on gastric emptying, antral motility and plasma motilin and pancreatic polypeptide concentrations in anorexia nervosa.
1993
Experimental pain induced by electrical and thermal stimulation of the skin in healthy man: sensitivity to 75 and 150 mg diclofenac sodium in comparison with 60 mg codeine and placebo.
1986
Intravenous Cisapride Accelerates Delayed Gastric Emptying and Increases Antral Contraction Amplitude in Patients With Primary Anorexia Nervosa
1987
Effects of a 5‐hydroxytryptamine3 receptor antagonist (ICS 205‐930) on colonic motor activity in healthy men.
1989
Oesophageal and gastric motor activity in patients with bulimia nervosa.
1990
Effects of the 5‐HT3 receptor antagonist ICS 205‐930 on fat‐delayed gastric emptying and antral motor activity.
1990
Fat preload delays gastric emptying: reversal by cisapride.
1990
Effects of cisapride on jejunal motor activity in fasting healthy humans
1986